Your session is about to expire
← Back to Search
Fasted Exercise for Type 2 Diabetes (FED Trial)
N/A
Waitlist Available
Led By Normand Boulé, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Physician diagnosed type 2 diabetes
Treated with diet and/or glucose lowering medications, but not insulin, for at least 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from the first two to the last two weeks of the 16 week interventions
Awards & highlights
FED Trial Summary
This trial will compare the effects of exercising in the morning before breakfast to exercising after breakfast in people with type 2 diabetes.
Eligible Conditions
- Type 2 Diabetes
FED Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFED Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from the first two to the last two weeks of the 16 week interventions
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from the first two to the last two weeks of the 16 week interventions
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Concentration of HbA1c (mmol/mol)
Liver fat (%)
Secondary outcome measures
Aerobic fitness
Body weight (kilograms)
Concentrations of Fasting glucose
+9 moreFED Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Fasted ExerciseExperimental Treatment1 Intervention
Exercise training will be performed in the fasted state (i.e., before breakfast).
Group II: Postprandial ExerciseActive Control1 Intervention
Exercise will be performed in the postprandial period (i.e., after breakfast)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fasted Exercise
2019
N/A
~40
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
883 Previous Clinical Trials
393,189 Total Patients Enrolled
Normand Boulé, PhDPrincipal InvestigatorUniversity of Alberta
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger